Peter van Vlasselaer
Presidente en Amphivena Therapeutics, Inc. .
Origen de la red de primer grado Peter van Vlasselaer.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Subsidiary | Biotechnology | 34 | |
| Subsidiary | Pharmaceuticals: Major | 16 | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California.
16
| Subsidiary | Investment Managers | 16 |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY.
12
| Holding Company | Pharmaceuticals: Major | 12 |
| Extinct | Medical Specialties | 11 | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA.
10
| Holding Company | Drugstore Chains | 10 |
Comet Therapeutics, Inc.
 Comet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Asceneuron SA
 Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Arresto BioSciences, Inc.
 Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Avidia, Inc.
 Avidia, Inc. Pharmaceuticals: MajorHealth Technology Avidia, Inc. developed pharmaceutical products. The company developed a novel, proprietary class of small therapeutic proteins. The company was headquartered in Mountain View, CA.
4
| Extinct | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Peter van Vlasselaer a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Consultant / Advisor Chief Executive Officer Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member Private Equity Investor Compliance Officer Director of Finance/CFO Comptroller/Controller/Auditor Private Equity Investor | |
| Stanford University | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Private Equity Investor Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Private Equity Investor | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Chairman Founder Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Consultant / Advisor President Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Auxogyn, Inc.
 Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| Santa Clara University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
| DESIGN THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| University of California, Davis | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | Comptroller/Controller/Auditor Chief Executive Officer Corporate Officer/Principal | |
| PROGYNY, INC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
NanoDimension Management Ltd.
 NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Operating Officer | |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| University of London | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Tufts University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
Dren Bio, Inc.
 Dren Bio, Inc. BiotechnologyHealth Technology Dren Bio, Inc. operates as a biotechnology company. It focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. The company was founded by John Wesley and Nenad Tomasevic in 2019 and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Director/Board Member | |
IlluminOss Medical, Inc.
 IlluminOss Medical, Inc. Medical SpecialtiesHealth Technology IlluminOss Medical, Inc. engages in the designing, developing, and marketing of orthopedic fracture repair products. The company was founded by Robert A. Rabiner and Arnold-Peter C. Weiss in 2007 and is headquartered in East Providence, RI. | Medical Specialties | Director/Board Member Director/Board Member | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 44 |
| Reino Unido | 5 |
| Irlanda | 2 |
| Suiza | 2 |
| Dinamarca | 2 |
Sectorial
| Health Technology | 28 |
| Consumer Services | 17 |
| Finance | 6 |
| Commercial Services | 3 |
Operativa
| Director/Board Member | 759 |
| Corporate Officer/Principal | 218 |
| Independent Dir/Board Member | 171 |
| Chairman | 103 |
| Chief Tech/Sci/R&D Officer | 81 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Michael Smith | 56 |
| Antoine Papiernik | 48 |
| Pierre Legault | 45 |
| Jonathan Leff | 45 |
| Luke Evnin | 42 |
| Beth Seidenberg | 39 |
| Eric Rowinsky | 36 |
| Mark McDade | 35 |
| Dieter Weinand | 32 |
| William Ringo | 32 |
| Jim Woody | 31 |
| Xiang Ming Cui | 31 |
| Nancy T. Chang | 31 |
| Roel Bulthuis | 29 |
- Bolsa de valores
- Insiders
- Peter van Vlasselaer
- Conexiones Empresas
